Riskpilot← Back to searchSign inGet full accessAbubaca Oy
OYDissolvedY-tunnus 2803561-9Makasiininkatu 6-A32Dental practice care activities · NACE 8623Est. 20171 employees
Revenue 2024
EUR 245K
-13% vs 2023
EBITDA margin
22.1%
-55% vs 2023
Equity ratio
91.8%
Financial strength
Net profit 2024
EUR 28K
-70% vs 2023
| Revenue | EUR 245K | -13% |
| EBITDA | EUR 54K | -55% |
| Net profit | EUR 28K | -70% |
| Total assets | EUR 419K | -8% |
| Equity | EUR 385K | -1% |
| Employees | 1 | — |
Legal name
Abubaca Oy
Y-tunnus number
2803561-9
Legal form
Osakeyhtiö
NACE code
8623 · Dental practice care activities
Founded
1. tammikuuta 2017
Share capital
EUR 2 500
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Hallituksen jäsen yksin
Company purpose
Lääkäri- ja hammaslääkäripalvelut, Muu sijoitustoiminta, Arvopapereiden kauppa ja hallinta, Kiinteistöalan toiminta, Rahoitustoiminta.
Address
Makasiininkatu 6-A32
Phone
+358405578412
Email
abubacaoy@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 358 | 474 | 332 | 283 | 245 |
| Staff expenses | −56 | −52 | −19 | −5 | −39 |
| EBITDA | 112 | 149 | 192 | 120 | 54 |
| Depreciation & amort. | −14 | −10 | −9 | −7 | −5 |
| EBIT | 98 | 138 | 184 | 114 | 49 |
| Net financials | −4 | −2 | −3 | 2 | −14 |
| Profit before tax | 94 | 136 | 180 | 116 | 35 |
| Tax | 19 | 27 | 10 | 24 | 7 |
| Net profit | 75 | 109 | 171 | 92 | 28 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 339 | 424 | 452 | 454 | 419 |
| Equity | 215 | 307 | 322 | 388 | 385 |
| Long-term debt | 100 | 90 | 37 | 10 | 2 |
| Short-term debt | 25 | 28 | 94 | 56 | 32 |
| Total debt | 124 | 118 | 131 | 66 | 34 |
EBITDA margin
22.1%
This company
15.8%
Market median
+40% vs market
20202024
Equity ratio
91.8%
This company
38.2%
Market median
+140% vs market
20202024
Return on equity
7.3%
This company
18.4%
Market median
-60% vs market
20202024
Net profit margin
11.4%
This company
8.1%
Market median
+41% vs market
20202024
Asset turnover
0.58×
This company
1.12×
Market median
-48% vs market
20202024
Debt / equity
0.09×
This company
0.62×
Market median
+85% vs market
20202024
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
JO Deputy Member | Deputy Member | 2017 |
PO Chief Executive Officer | Chief Executive Officer | 2017 |
| Former (1) | ||
AM | Audit | 2019 – 2023 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Abubaca Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ari-Pekka Markus Poikonen | Audit | 0 companies |
| Jari Olavi Mutanen | Deputy Member | 0 companies |
| Pekka Oskari Mutanen | Chief Executive Officer | 0 companies |